Lificiguat
Lificiguat, also known as YC-1, is a inhibitor of Hypoxia-inducible factor-1alpha (HIF-1alpha) . YC-1 is widely used as a potent inhibitor of HIF-1alpha both in vitro and in vivo, and is also being developed as a novel anticancer drug. YC-1 effectively inhibits tumor invasion and metastasis, and imply that YC-1 is worth while to further develop as a multipurpose anticancer drug.
Product Specifications
CAS Number
170632-47-0
Product Name Alternative
YC1 | YC 1 | YC-1 | Lificiguat
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 51 mg/mL; 167.58 mM
Smiles
OCC1=CC=C (C2=NN (CC3=CC=CC=C3) C4=C2C=CC=C4) O1
Molecular Formula
C19H16N2O2
Molecular Weight
304.34
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
5-?[1-? (phenylmethyl) -?1H-?indazol-?3-?yl]-?2-?furanmethanol
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7025312-01 0.02 mg
Recombinant Pseudomonas phage phi6 Major envelope protein (P9)
Sign In for Pricing
View Details MBS7025312-02 0.1 mg
Recombinant Pseudomonas phage phi6 Major envelope protein (P9)
Sign In for Pricing
View Details MBS7025312-03 5x 0.1 mg
Recombinant Pseudomonas phage phi6 Major envelope protein (P9)
Sign In for Pricing
View Details 